A Phase 2, 28 Day Parallel-Group, Double-Masked, Dose-Finding Study Comparing the Safety and Efficacy of PF-03187207 to Latanoprost
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Bausch & Lomb Incorporated
- Enrollment
- 176
- Locations
- 1
- Primary Endpoint
- Change From Baseline Mean Diurnal Intraocular Pressure (IOP) in the Study Eye on Day 28
Overview
Brief Summary
This study will evaluate the safety and efficacy of PF 03187207.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Care Provider, Investigator)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosis of primary open angle glaucoma (including pigmentary or pseudoexfoliative) or ocular hypertension in one or both eyes
Exclusion Criteria
- •Closed or barely open anterior chamber angle or a history of acute angle closure in either eye
Arms & Interventions
PF-03187207 and Latanoprost Vehicle
One drop of each, once daily in study eye for 28 days
Intervention: PF-03187207 and Latanoprost Vehicle (Drug)
Latanoprost 0.005% and PF-03187207 Vehicle
One drop of each, once daily in study eye for 28 days
Intervention: Latanoprost 0.005% and PF-03187207 Vehicle (Drug)
Outcomes
Primary Outcomes
Change From Baseline Mean Diurnal Intraocular Pressure (IOP) in the Study Eye on Day 28
Time Frame: Baseline, 28 days
Intraocular pressure (IOP) was measured using a Goldmann applanation tonometer. Diurnal IOP, defined as the mean IOP over the day based on values obtained at 8 AM, 10 AM, 1 PM, and 4 PM, was calculated for each visit. Both eyes were tested, with the right eye preceding the left eye. The operator initially set the dial at 10 mmHg, then looked through the slit lamp and adjusted the dial to take the reading, and then recorded the results. The procedure was repeated on the same eye twice consecutively. If the measurements were within 2 mmHg or less of each other, the mean of the 2 readings was recorded as the IOP at that time point. If the 2 readings were more than 2 mmHg of each other, a third (consecutive) reading was taken and the median (middle) IOP was recorded as the IOP at that time point.
Secondary Outcomes
- Change From Baseline in Mean Intraocular Pressure IOP at the Day 7, 14, and 21 Visits(Baseline, Day 7, Day 14, and Day 21)
- Percentage of Participants With Intraocular Pressure (IOP) Less Than or Equal to 18 mmHg at Any Visit Through Day 28(28 days)